Purchase Order 75F40123P00330
Award Date 8/24/23
Potential Completion Date 1/11/24
Potential Value $23K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Global Life Sciences Solutions USA LLC, a subsidiary of Danaher Corporation, was awarded a firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration for $17,733. The contract has no set-aside designation and is to be completed by September 8, 2021. Under this contract, Global Life Sciences Solutions will provide scientific equipment, supplies, and services to support the FDA's biomedical research and laboratory operations in Silver Spring,...
- The Department of Health and Human Services Food and Drug Administration awarded a $35,593.65 firm fixed price delivery order to Global Life Sciences Solutions USA LLC under the Scientific Equipment and Services Federal Supply Schedule contract. This order is for the delivery of a fast protein liquid chromatography system to the agency's facility in Silver Spring, Maryland by August 27, 2020. Global Life Sciences Solutions USA LLC is a subsidiary of Danaher Corporation and will provide the...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $368,778.39 delivery order contract to Global Life Sciences Solutions USA LLC under its Multiple Award Schedule contract vehicle. The contract calls for Global Life Sciences Solutions USA LLC to provide one Biacore T200 Surface Plasmon Resonance system to be delivered to the place of performance in Marlborough, Massachusetts by November 28, 2023. The pricing for this firm fixed price contract is fixed...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Global Life Sciences Solutions USA LLC, a subsidiary of Danaher Corporation, for the procurement of Cytiva cell supplies. The firm-fixed-price contract has a ceiling value of $24,999.72 and an ultimate completion date of July 4, 2025. Global Life Sciences Solutions USA LLC is a for-profit limited liability company that specializes in providing scientific equipment, maintenance services,...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a firm fixed-price delivery order contract to Global Life Sciences Solutions USA LLC for the purchase of an "AKTA PURE 25L SYSTEM WITH 4 (1-YEAR POST-WARRANTY MAINTENANCE OPTION PERIODS)" valued at $85,288.67. The contract was awarded on June 22, 2021 and has a completion date of August 31, 2026. The contract was not set aside for a specific business type. Global Life Sciences Solutions USA LLC...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC, a subsidiary of Danaher Corporation. The contract is for the provision of a Surface Plasmon Resonance (SPR) system and associated maintenance services, with a ceiling value of $394,811.23 and a performance period ending on August 18, 2021. The contract was issued under the General Services Administration (GSA) Scientific Equipment and Services Federal Supply...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC for preventive maintenance and repair services for a Cytiva Biacore T200 surface plasmon resonance (SPR) instrument. The contract has a ceiling value of $83,520.00 and a period of performance through August 18, 2025. No set-aside designation was used. Global Life Sciences Solutions USA LLC is a provider of technologies and services that advance and accelerate...
- This is a $248,856.96 firm-fixed price purchase order awarded to Global Life Sciences Solutions USA LLC by the Food and Drug Administration (FDA) for a Cytiva Xcellerex XDuo 100 L jacketed mixer and accessories. The award has an ultimate completion date of November 24, 2025 and does not utilize a set-aside. Global Life Sciences Solutions USA LLC is a for-profit limited liability company that manufactures and provides scientific equipment, maintenance services, biological materials, and medical...
- This is a $14,248.83 firm-fixed-price purchase order awarded to Global Life Sciences Solutions USA LLC, a subsidiary of Danaher Corporation, by the National Institute of Environmental Health Sciences. The contract is for the procurement of CYTIVA SUPERDEX 200 PG, XK 50/100,90-95 CM laboratory equipment. No set-aside was used. This purchase appears to be part of a larger $100 million Blanket Purchase Agreement that Global Life Sciences Solutions USA LLC holds with the National Institutes of...
- The Food and Drug Administration (FDA) awarded a $465,096.00 firm fixed-price purchase order to Global Life Sciences Solutions USA LLC for the delivery of an XDR-50 single use bioreactor system or equivalent with accessories, training, and installation. The bioreactor system will support the FDA's Center for Drug Evaluation and Research Division of Product Quality Research. The contract has a two-year manufacturer's warranty and a performance period through May 18, 2025. This award was not set...
Global Life Sciences Solutions USA LLC, a subsidiary of Danaher Corporation, has been awarded a $23,365 firm fixed price purchase order by the Department of Health and Human Services' Food and Drug Administration to provide Cytiva ReadyKart consumables. The contract has a period of performance from August 2024 through January 2025 for use at the prime contractor's place of performance in Marlborough, Massachusetts. ReadyKart is a consumable product line that supports the FDA's laboratory operations. No subcontractors or set aside designations were identified. The award is likely associated with the FDA's broader programs and initiatives involving product testing and review.
Generated 12/23/23, 9:51 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 8/24/23 |